ArticleJHEP reports : innovation in hepatology2024

Atezolizumab/bevacizumab or lenvatinib in hepatocellular carcinoma: Multicenter real-world study with focus on bleeding and thromboembolic events.

Najib Ben Khaled et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.